Biomarkers of Epileptogenesis: Psychiatric Comorbidities (?)

被引:53
作者
Kanner, Andres M. [1 ]
Mazarati, Andrey [2 ,3 ]
Koepp, Matthias [4 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA
[2] Univ Calif Los Angeles, Dept Pediat, D Geffen Sch Med, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, D Geffen Sch Med, Childrens Discovery & Innovat Inst, Los Angeles, CA USA
[4] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England
关键词
Major depressive disorder; Serotonin; Opioids; Selective serotonin-reuptake inhibitors; Hypothalamic-pituitary-adrenal axis; Glutamate; GABA; TEMPORAL-LOBE EPILEPSY; MAJOR DEPRESSIVE DISORDER; POSITRON-EMISSION-TOMOGRAPHY; 5-HT1A RECEPTOR-BINDING; GAMMA-AMINOBUTYRIC-ACID; PITUITARY-ADRENAL AXIS; AMYGDALA KINDLING EPILEPTOGENESIS; CORTICOTROPIN-RELEASING HORMONE; INCIDENT UNPROVOKED SEIZURES; TUBEROUS SCLEROSIS COMPLEX;
D O I
10.1007/s13311-014-0271-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The last decade has witnessed a significant shift on our understanding of the relationship between psychiatric disorders and epilepsy. While traditionally psychiatric disorders were considered as a complication of the underlying seizure disorder, new epidemiologic data, supported by clinical and experimental research, have suggested the existence of a bidirectional relation between the two types of conditions: not only are patients with epilepsy at greater risk of experiencing a psychiatric disorder, but patients with primary psychiatric disorders are at greater risk of developing epilepsy. Do these data suggest that some of the pathogenic mechanisms operant in psychiatric comorbidities play a role in epileptogenesis? The aim of this article is to review the epidemiologic data that demonstrate that primary psychiatric disorders are more frequent in people who develop epilepsy, before the onset of the seizure disorder than among controls. The next question looks at the available data of pathogenic mechanisms of primary mood disorders and their potential for facilitating the development and/or exacerbation in the severity of epileptic seizures. Finally, we review data derived from experimental studies in animal models of depression and epilepsy that support a potential role of pathogenic mechanisms of mood disorders in the development of epileptic seizures and epileptogenesis. The data presented in this article do not yet establish conclusive evidence of a pathogenic role of psychiatric comorbidities in epileptogenesis, but raise important research questions that need to be investigated in experimental, clinical, and population-based epidemiologic research studies.
引用
收藏
页码:358 / 372
页数:15
相关论文
共 194 条
[1]   Neuropsychiatric morbidity in focal epilepsy [J].
Adams, Sophia J. ;
O'Brien, Terence J. ;
Lloyd, John ;
Kilpatrick, Christine J. ;
Salzberg, Michael R. ;
Velakoulis, Dennis .
BRITISH JOURNAL OF PSYCHIATRY, 2008, 192 (06) :464-469
[2]   Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy [J].
Adelow, Cecilia ;
Andersson, Tomas ;
Ahlbom, Anders ;
Tomson, Torbjorn .
NEUROLOGY, 2012, 78 (06) :396-401
[3]  
Aghajanian GK., 1990, ANN NY ACAD SCI, V600, P93
[4]   Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats [J].
Aisa, Barbara ;
Tordera, Rosa ;
Lasheras, Berta ;
Del Rio, Joaquin ;
Ramirez, Maria J. .
PSYCHONEUROENDOCRINOLOGY, 2007, 32 (03) :256-266
[5]  
ALBERTSON TE, 1984, J PHARMACOL EXP THER, V228, P620
[6]   Seizure incidence in psychopharmacological clinical trials: An analysis of food and drug administration (FDA) summary basis of approval reports [J].
Alper, Kenneth ;
Schwartz, Kelly A. ;
Kolts, Russell L. ;
Khan, Arif .
BIOLOGICAL PSYCHIATRY, 2007, 62 (04) :345-354
[7]   Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses [J].
Arnone, D. ;
McIntosh, A. M. ;
Ebmeier, K. P. ;
Munafo, M. R. ;
Anderson, I. M. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (01) :1-16
[8]   Evidence for impaired cortical inhibition in patients with unipolar major depression [J].
Bajbouj, M ;
Lisanby, SH ;
Lang, UE ;
Danker-Hopfe, H ;
Heuser, I ;
Neu, P .
BIOLOGICAL PSYCHIATRY, 2006, 59 (05) :395-400
[9]   Fluoxetine dose and outcome in antidepressant drug trials [J].
Barbui, C ;
Hotopf, M ;
Garattini, S .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (06) :379-386
[10]   Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression [J].
Barioni Salgado, Priscila Camile ;
Yasuda, Clarissa Lin ;
Cendes, Fernando .
EPILEPSY & BEHAVIOR, 2010, 19 (03) :422-427